ADMA Biologics Inc vs United States Brent Oil Fund LP — how do they compare? ADMA Biologics Inc trades at $9.86 (market cap $2.22B), while United States Brent Oil Fund LP trades at $50.53. The key difference: United States Brent Oil Fund LP is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | BNO | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Commodities - Energy |
52-Week High | $20.38 | $60.13 |
52-Week Low | $7.60 | $27.20 |
Enterprise Value | $2.29B | — |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.
Read more on BNO →